Ftse Mib
34.676,17
1,15%
DAX
19.254,97
1,03%
S&P 500
5.728,80
0,41%
NASDAQ
18.239,92
0,80%
Bitcoin
69.651,50
0,24%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Akero Therapeutics Inc (AKRO) Akero Therapeutics Inc (AKRO) Notizie

Akero Therapeutics Inc

AKRO
32,33
1,50 (4,87%)
02 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/11/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202421:46EDGAR2Form 144 - Report of proposed sale of securities
21/10/202413:00GLOBEAkero Therapeutics to Present Data Reinforcing the Efficacy..
19/10/202402:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:50EDGAR2Form 144 - Report of proposed sale of securities
15/10/202422:38EDGAR2Form 144 - Report of proposed sale of securities
15/10/202414:04EDGAR2Form 144 - Report of proposed sale of securities
04/10/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:03EDGAR2Form 144 - Report of proposed sale of securities
01/10/202403:37PRNUSINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors..
30/9/202413:00GLOBEAkero Therapeutics to Present at the H.C. Wainwright 8th..
24/9/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202403:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202422:34EDGAR2Form 144 - Report of proposed sale of securities
13/9/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202413:00GLOBEAkero Therapeutics Announces First Patient Dosed in Phase 3..
05/9/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:05GLOBEAkero Therapeutics to Present at the Morgan Stanley 22nd..
28/8/202417:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202422:32EDGAR2Form 144 - Report of proposed sale of securities
23/8/202422:27EDGAR2Form 144 - Report of proposed sale of securities
20/8/202417:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202413:15EDGAR2Form 8-K - Current report
09/8/202413:00GLOBEAkero Therapeutics Reports Second Quarter 2024 Financial..
03/8/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:25EDGAR2Form 144 - Report of proposed sale of securities
19/7/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:04EDGAR2Form 144 - Report of proposed sale of securities
14/6/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:23EDGAR2Form 8-K - Current report
11/6/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202413:00GLOBEAkero Therapeutics Announces Initiation of Phase 3 SYNCHRONY..
Apertura: 31,885 Min: 30,92 Max: 32,95
Chiusura: 30,83

La tua Cronologia

NASDAQ
AKRO
Akero Therapeutics
NYSE
LXU
LSB Industries
LSE
34ZD
Anz Nz.25
USOTC
ELUXY
AB Electrolux (PK)
NASDAQ
ZAETCX
Arthur Ventures Growth F...
NASDAQ
WPRT
Westport Fuel Systems
NASDAQ
PAYX
Paychex
BIT
P22C14
NLBNPIT22C14 20991231 1....
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network